SVB Leerink Boosts NeoGenomics (NASDAQ:NEO) Price Target to $60.00

SVB Leerink Boosts NeoGenomics (NASDAQ:NEO) Price Target to $60.00 Posted by Charles Blunt on Jan 8th, 2021
NeoGenomics (NASDAQ:NEO) had its target price increased by stock analysts at SVB Leerink from $50.00 to $60.00 in a research report issued on Friday, Stock Target Advisor reports. The brokerage currently has an “outperform” rating on the medical research company’s stock. SVB Leerink’s price objective would suggest a potential upside of 12.11% from the stock’s current price.
Other analysts …

Original Source